Inpharma Weekly

, Volume 754, Issue 1, pp 6–7 | Cite as

CQA 206291: has antiparkinsonian activity as monotherapy, and as additional therapy in patients with insufficient response to levodopa

Newsletter Article


Levodopa Orthostatic Hypotension Dopamine Agonist Evaluable Patient Additional Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1990

Personalised recommendations